Permira agrees £703m takeover of Ergomed

Headline – Permira agrees £703m takeover of Ergomed

Deal Type – Acquisition

Acquiring Company – Permira

Target Company – Ergomed

Target Company Services – Drug Trials

Deal Valuation (if available) – £703 m

Country of Target – UK

Continent – Europe

Target Company Industry – Healthcare

Deal Rationale – Acquisition of Ergomed by Permira, a deal that allows shareholders to realize value and supports Ergomed’s growth strategy.

Deal Summary – Private equity firm Permira has agreed to acquire Ergomed, a company that manages drug trials and monitors participants for side effects. The offer of 1,350p per share represents a 28.3% premium to the company’s share price.

Company Insight provides expert company research services. If you are looking for company research or market analysis services please get in touch